The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...

According to 2021 data from the American Diabetes Association, 2 million Americans have type 1 diabetes—304,000 of which are ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes ...

Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...

Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...

Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.

President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...